Peru's First Angelman Clinic Opens at Ricardo Palma Clinic
Clínica Ricardo Palma has inaugurated Peru's first specialized Angelman Clinic, aiming to provide comprehensive, multidisciplinary care for individuals with this rare genetic neurodevelopmental disorder. This initiative centralizes services, reducing the need for families to navigate multiple healthcare facilities and improving patient follow-up. The clinic's opening marks a significant step in addressing the challenges faced by approximately 1 in 15,000 people affected by Angelman syndrome. Specialists anticipate this coordinated model will enhance diagnosis and treatment, alleviate caregiver stress, and foster a more supportive environment for patients and their families.
Angelman syndrome, caused by alterations in chromosome 15, leads to severe developmental delays, intellectual disability, limited language, motor impairments, and epilepsy, necessitating simultaneous care from various medical disciplines. The clinic consolidates expertise in pediatric neurology, ophthalmology, gastroenterology, sleep medicine, nutrition, psychology, and orthopedics, adapting plans to each child's unique needs. Initiated by Omar Vélez, with support from FAST LatAm and Clínica Ricardo Palma, the project is the culmination of years of collaborative effort. The clinic has identified around 25 patients in Peru and plans to expand its reach, improving the quality of life through better-coordinated treatments and timely medical attention.
The establishment of the first Angelman Clinic in Peru represents a systemic response to the challenges of rare disease management. By consolidating specialized medical services, the clinic addresses critical gaps in care coordination and accessibility, offering a patient-centric model that prioritizes efficiency and reduces familial burden. This initiative highlights the growing recognition of the need for integrated healthcare solutions for conditions that fall outside mainstream medical focus. Looking ahead, such specialized centers can serve as crucial hubs for data collection, potentially enabling Peru's participation in global research and the development of advanced genetic therapies, thereby bridging the gap between diagnosis and cutting-edge treatment options.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.